{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:12:51Z","timestamp":1792987971454,"version":"4.5.0"},"reference-count":182,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8,1]]},"DOI":"10.1210\/er.2010-0020","type":"journal-article","created":{"date-parts":[[2011,8,5]],"date-time":"2011-08-05T17:28:35Z","timestamp":1312565315000},"page":"498-514","source":"Crossref","is-referenced-by-count":318,"title":["Genetic Syndromes of Severe Insulin Resistance"],"prefix":"10.1210","volume":"32","author":[{"given":"Robert K.","family":"Semple","sequence":"first","affiliation":[{"name":"University of Cambridge Metabolic Research Laboratories (R.K.S., D.B.S., S.O.), Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Savage","sequence":"additional","affiliation":[{"name":"University of Cambridge Metabolic Research Laboratories (R.K.S., D.B.S., S.O.), Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine K.","family":"Cochran","sequence":"additional","affiliation":[{"name":"Clinical Endocrinology Branch (E.K.C., P.G.), National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Gorden","sequence":"additional","affiliation":[{"name":"Clinical Endocrinology Branch (E.K.C., P.G.), National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"O'Rahilly","sequence":"additional","affiliation":[{"name":"University of Cambridge Metabolic Research Laboratories (R.K.S., D.B.S., S.O.), Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2011,5,2]]},"reference":[{"key":"2019041121361173100_B1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/diacare.26.3.861","article-title":"Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study","volume":"26","author":"Resnick","year":"2003","journal-title":"Diabetes Care"},{"key":"2019041121361173100_B2","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.2337\/diabetes.51.10.3120","article-title":"Components of the \u201cmetabolic syndrome\u201d and incidence of type 2 diabetes","volume":"51","author":"Hanson","year":"2002","journal-title":"Diabetes"},{"key":"2019041121361173100_B3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"2019041121361173100_B4","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"2019041121361173100_B5","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s00125-007-0784-z","article-title":"Anthropometry, carbohydrate and lipid metabolism in the East Flanders Prospective Twin Survey: heritabilities","volume":"50","author":"Souren","year":"2007","journal-title":"Diabetologia"},{"key":"2019041121361173100_B6","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1046\/j.1464-5491.2002.00843.x","article-title":"Heritability of features of the insulin resistance syndrome in a community-based study of healthy families","volume":"19","author":"Freeman","year":"2002","journal-title":"Diabet Med"},{"key":"2019041121361173100_B7","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00125-004-1338-2","article-title":"Heritability estimates for \u03b2-cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes","volume":"47","author":"Mills","year":"2004","journal-title":"Diabetologia"},{"key":"2019041121361173100_B8","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.2337\/db07-0708","article-title":"Quantitative linkage analysis for pancreatic B-cell function and insulin resistance in a large twin cohort","volume":"57","author":"Falchi","year":"2008","journal-title":"Diabetes"},{"key":"2019041121361173100_B9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197604012941401","article-title":"The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man","volume":"294","author":"Kahn","year":"1976","journal-title":"N Engl J Med"},{"key":"2019041121361173100_B10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM197602262940902","article-title":"The complement abnormalities of lipodystrophy","volume":"294","author":"Sissons","year":"1976","journal-title":"N Engl J Med"},{"key":"2019041121361173100_B11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2008-1703","article-title":"Complement abnormalities in acquired lipodystrophy revisited","volume":"94","author":"Savage","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00005792-200203000-00001","article-title":"Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective","volume":"81","author":"Arioglu","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"2019041121361173100_B13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005792-200303000-00007","article-title":"Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature","volume":"82","author":"Misra","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"2019041121361173100_B14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.md.0000111061.69212.59","article-title":"Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature","volume":"83","author":"Misra","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"2019041121361173100_B15","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"2019041121361173100_B16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1056\/NEJM197902223000808","article-title":"Receptors, antireceptor antibodies and mechanisms of insulin resistance","volume":"300","author":"Flier","year":"1979","journal-title":"N Engl J Med"},{"key":"2019041121361173100_B17","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.2337\/diabetes.53.6.1592","article-title":"A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene","volume":"53","author":"H\u00f8jlund","year":"2004","journal-title":"Diabetes"},{"key":"2019041121361173100_B18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cmet.2006.09.003","article-title":"Non-DNA binding, dominant-negative, human PPAR\u03b3 mutations cause lipodystrophic insulin resistance","volume":"4","author":"Agostini","year":"2006","journal-title":"Cell Metab"},{"key":"2019041121361173100_B19","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.1096706","article-title":"A family with severe insulin resistance and diabetes due to a mutation in AKT2","volume":"304","author":"George","year":"2004","journal-title":"Science"},{"key":"2019041121361173100_B20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.gastro.2008.03.021","article-title":"Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes","volume":"135","author":"Kotronen","year":"2008","journal-title":"Gastroenterology"},{"key":"2019041121361173100_B21","doi-asserted-by":"crossref","first-page":"8977","DOI":"10.1073\/pnas.0608703104","article-title":"Insulin receptors in \u03b2-cells are critical for islet compensatory growth response to insulin resistance","volume":"104","author":"Okada","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361173100_B22","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1210\/jc.2002-020922","article-title":"The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women","volume":"88","author":"Kaltsas","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/edrv.20.4.0374","article-title":"The insulin-related ovarian regulatory system in health and disease","volume":"20","author":"Poretsky","year":"1999","journal-title":"Endocr Rev"},{"key":"2019041121361173100_B24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17 \u03b1 activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"N Engl J Med"},{"key":"2019041121361173100_B25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2265.2005.02302.x","article-title":"Clinical evidence that hyperinsulinaemia independent of gonadotropins stimulates ovarian growth","volume":"63","author":"Musso","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121361173100_B26","first-page":"545","article-title":"Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization","volume":"66","author":"Dunaif","year":"1985","journal-title":"Obstet Gynecol"},{"key":"2019041121361173100_B27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1365-2265.2003.01792.x","article-title":"Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?","volume":"59","author":"Kaltsas","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121361173100_B28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3109\/15513819309048242","article-title":"Congenital bilateral juvenile granulosa cell tumor of the ovary in leprechaunism: a case report","volume":"13","author":"Brisigotti","year":"1993","journal-title":"Pediatr Pathol"},{"key":"2019041121361173100_B29","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1365-2133.2002.05150.x","article-title":"Genes, growth factors and acanthosis nigricans","volume":"147","author":"Torley","year":"2002","journal-title":"Br J Dermatol"},{"key":"2019041121361173100_B30","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJM198712173172506","article-title":"Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trelat, and multiple acrochordons. A possible role for \u03b1-transforming growth factor in cutaneous paraneoplastic syndromes","volume":"317","author":"Ellis","year":"1987","journal-title":"N Engl J Med"},{"key":"2019041121361173100_B31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00128071-200405030-00008","article-title":"Acanthosis nigricans associated with insulin resistance: pathophysiology and management","volume":"5","author":"Hermanns-L\u00ea","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"2019041121361173100_B32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1464-5491.2008.02621.x","article-title":"Severe insulin resistance due to anti-insulin antibodies: response to plasma exchange and immunosuppressive therapy","volume":"26","author":"Greenfield","year":"2009","journal-title":"Diabet Med"},{"key":"2019041121361173100_B33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2133.1988.tb02561.x","article-title":"Acanthosis nigricans, insulin resistance and cutaneous virilism","volume":"118","author":"Barth","year":"1988","journal-title":"Br J Dermatol"},{"key":"2019041121361173100_B34","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jc.2006-0587","article-title":"Review: the role of insulin resistance in nonalcoholic fatty liver disease","volume":"91","author":"Utzschneider","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7326\/0003-4819-132-2-200001180-00004","article-title":"Prevalence of and risk factors for hepatic steatosis in northern Italy","volume":"132","author":"Bellentani","year":"2000","journal-title":"Ann Intern Med"},{"key":"2019041121361173100_B36","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.2337\/diabetes.53.7.1782","article-title":"Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study","volume":"53","author":"Bonora","year":"2004","journal-title":"Diabetes"},{"key":"2019041121361173100_B37","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/oby.2000.79","article-title":"Body mass index and the prevalence of hypertension and dyslipidemia","volume":"8","author":"Brown","year":"2000","journal-title":"Obes Res"},{"key":"2019041121361173100_B38","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"2019041121361173100_B39","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J Clin Invest"},{"key":"2019041121361173100_B40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.md.0000133625.73570.54","article-title":"Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective","volume":"83","author":"Musso","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"2019041121361173100_B41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1097-2765(05)00010-9","article-title":"Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob\/ob mice","volume":"6","author":"Shimomura","year":"2000","journal-title":"Mol Cell"},{"key":"2019041121361173100_B42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmet.2007.11.013","article-title":"Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis","volume":"7","author":"Biddinger","year":"2008","journal-title":"Cell Metab"},{"key":"2019041121361173100_B43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metab"},{"key":"2019041121361173100_B44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MOL.0b013e32833b7782","article-title":"Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance","volume":"21","author":"Savage","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"2019041121361173100_B45","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2008-0819","article-title":"Severe intrauterine growth retardation and atypical diabetes associated with a translocation breakpoint disrupting regulation of the insulin-like growth factor 2 gene","volume":"93","author":"Murphy","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B46","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/adc.88.4.332","article-title":"Hyperinsulinism and overgrowth without obesity","volume":"88","author":"Srinivasan","year":"2003","journal-title":"Arch Dis Child"},{"key":"2019041121361173100_B47","first-page":"1533","article-title":"Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance","volume":"76","author":"Flier","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B48","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/s-0029-1212090","article-title":"Insulin-mediated pseudoacromegaly in a patient with severe insulin resistance: association of defective insulin-stimulated glucose transport with impaired phosphatidylinositol 3-kinase activity in fibroblasts","volume":"107","author":"Kausch","year":"1999","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2019041121361173100_B49","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI119884","article-title":"Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly. A disorder characterized by selective postreceptor insulin resistance","volume":"101","author":"Dib","year":"1998","journal-title":"J Clin Invest"},{"key":"2019041121361173100_B50","first-page":"3465","article-title":"Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly","volume":"81","author":"Kumar","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B51","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1128\/MCB.19.5.3278","article-title":"Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells","volume":"19","author":"Frasca","year":"1999","journal-title":"Mol Cell Biol"},{"key":"2019041121361173100_B52","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"2019041121361173100_B53","first-page":"801","article-title":"Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions","volume":"18","author":"Rajaram","year":"1997","journal-title":"Endocr Rev"},{"key":"2019041121361173100_B54","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1349-7006.2010.01521.x","article-title":"Insulin resistance and cancer: epidemiological evidence","volume":"101","author":"Tsugane","year":"2010","journal-title":"Cancer Sci"},{"key":"2019041121361173100_B55","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/ajg.2009.541","article-title":"Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study","volume":"105","author":"Kang","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2019041121361173100_B56","first-page":"1776","article-title":"Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety)","volume":"85","author":"Garg","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B57","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1210\/jc.2007-2521","article-title":"Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy","volume":"93","author":"Vantyghem","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B58","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1073\/pnas.0914798107","article-title":"Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis","volume":"107","author":"Li","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361173100_B59","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1073\/pnas.1000323107","article-title":"mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis","volume":"107","author":"Laplante","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361173100_B60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"D\u00fcvel","year":"2010","journal-title":"Mol Cell"},{"key":"2019041121361173100_B61","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"2019041121361173100_B62","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MOL.0b013e32832b2024","article-title":"Dissecting the role of insulin resistance in the metabolic syndrome","volume":"20","author":"Haas","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"2019041121361173100_B63","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molmed.2007.04.002","article-title":"mTOR Complex 1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer","volume":"13","author":"Dann","year":"2007","journal-title":"Trends Mol Med"},{"key":"2019041121361173100_B64","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","article-title":"A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance","volume":"9","author":"Newgard","year":"2009","journal-title":"Cell Metab"},{"key":"2019041121361173100_B65","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2337\/dc08-2075","article-title":"Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women","volume":"32","author":"Huffman","year":"2009","journal-title":"Diabetes Care"},{"key":"2019041121361173100_B66","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.2337\/db06-1665","article-title":"Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies","volume":"56","author":"Semple","year":"2007","journal-title":"Diabetes"},{"key":"2019041121361173100_B67","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1210\/jc.2009-1824","article-title":"Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency","volume":"95","author":"Antuna-Puente","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B68","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.2337\/dc07-1342","article-title":"Elevated plasma adiponectin and leptin levels in sisters with genetically defective insulin receptors","volume":"30","author":"Hattori","year":"2007","journal-title":"Diabetes Care"},{"key":"2019041121361173100_B69","first-page":"2677","article-title":"Sex hormone-binding globulin and risk of type 2 diabetes","volume":"361","author":"Semple","year":"2009","journal-title":"N Engl J Med"},{"key":"2019041121361173100_B70","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2337\/dc07-2194","article-title":"Plasma adiponectin as a marker of insulin receptor dysfunction: clinical utility in severe insulin resistance","volume":"31","author":"Semple","year":"2008","journal-title":"Diabetes Care"},{"key":"2019041121361173100_B71","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2337\/dc05-1367","article-title":"IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance","volume":"29","author":"Maddux","year":"2006","journal-title":"Diabetes Care"},{"key":"2019041121361173100_B72","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/diacare.27.4.861","article-title":"Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat","volume":"27","author":"Tsai","year":"2004","journal-title":"Diabetes Care"},{"key":"2019041121361173100_B73","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B74","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1210\/jc.2006-0166","article-title":"Elevated plasma adiponectin in humans with genetically defective insulin receptors","volume":"91","author":"Semple","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B75","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1210\/jc.2009-2286","article-title":"Hypoadiponectinemia\u2014cause or consequence of human \u201cinsulin resistance\u201d?","volume":"95","author":"Cook","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B76","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0002-9378(83)90091-1","article-title":"Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features","volume":"147","author":"Barbieri","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121361173100_B77","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.2834824","article-title":"Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance","volume":"240","author":"Kadowaki","year":"1988","journal-title":"Science"},{"key":"2019041121361173100_B78","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1126\/science.3283938","article-title":"Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing","volume":"240","author":"Yoshimasa","year":"1988","journal-title":"Science"},{"key":"2019041121361173100_B79","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/313756a0","article-title":"Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes","volume":"313","author":"Ullrich","year":"1985","journal-title":"Nature"},{"key":"2019041121361173100_B80","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/ajcp\/26.3.283","article-title":"Familial hypertrophy of pineal body, hyperplasia of adrenal cortex and diabetes mellitus; report of 3 cases","volume":"26","author":"Rabson","year":"1956","journal-title":"Am J Clin Pathol"},{"key":"2019041121361173100_B81","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-3476(54)80113-2","article-title":"Leprechaunism: a euphemism for a rare familial disorder","volume":"45","author":"Donohue","year":"1954","journal-title":"J Pediatr"},{"key":"2019041121361173100_B82","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-374430-2.00004-3","article-title":"Syndromes of severe insulin resistance and\/or lipodystrophy.","volume-title":"Genetic diagnosis of endocrine disorders.","author":"Semple","year":"2010"},{"key":"2019041121361173100_B83","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jcem.86.7.7631","article-title":"Hypoglycemia and resistance to ketoacidosis in a subject without functional insulin receptors","volume":"86","author":"Ogilvy-Stuart","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B84","first-page":"998","article-title":"Reduced mRNA and a nonsense mutation in the insulin-receptor gene produce heritable severe insulin resistance","volume":"50","author":"Longo","year":"1992","journal-title":"Am J Hum Genet"},{"key":"2019041121361173100_B85","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nm1254","article-title":"Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice","volume":"11","author":"Foti","year":"2005","journal-title":"Nat Med"},{"key":"2019041121361173100_B86","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1464-5491.2002.00779.x","article-title":"Genetic variants of insulin receptor substrate-1 (IRS-1) in syndromes of severe insulin resistance. Functional analysis of Ala513Pro and Gly1158Glu IRS-1","volume":"19","author":"Berger","year":"2002","journal-title":"Diabet Med"},{"key":"2019041121361173100_B87","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2337\/diabetes.47.5.837","article-title":"Molecular scanning of the insulin receptor substrate 1 gene in subjects with severe insulin resistance: detection and functional analysis of a naturally occurring mutation in a YMXM motif","volume":"47","author":"Whitehead","year":"1998","journal-title":"Diabetes"},{"key":"2019041121361173100_B88","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1007\/s00125-009-1345-4","article-title":"IRS2 variants and syndromes of severe insulin resistance","volume":"52","author":"Bottomley","year":"2009","journal-title":"Diabetologia"},{"key":"2019041121361173100_B89","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2337\/db06-0921","article-title":"Analysis of genetic variation in Akt2\/PKB-\u03b2 in severe insulin resistance, lipodystrophy, type 2 diabetes, and related metabolic phenotypes","volume":"56","author":"Tan","year":"2007","journal-title":"Diabetes"},{"key":"2019041121361173100_B90","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s001250050050","article-title":"Natural variants of human p85 \u03b1 phosphoinositide 3-kinase in severe insulin resistance: a novel variant with impaired insulin-stimulated lipid kinase activity","volume":"43","author":"Baynes","year":"2000","journal-title":"Diabetologia"},{"key":"2019041121361173100_B91","doi-asserted-by":"crossref","first-page":"9350","DOI":"10.1073\/pnas.0900909106","article-title":"A truncation mutation in TBC1D4 in a family with acanthosis nigricans and postprandial hyperinsulinemia","volume":"106","author":"Dash","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361173100_B92","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ng0398-292","article-title":"Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21\u201322","volume":"18","author":"Peters","year":"1998","journal-title":"Nat Genet"},{"key":"2019041121361173100_B93","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","article-title":"Nuclear lamin A\/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy","volume":"9","author":"Cao","year":"2000","journal-title":"Hum Mol Genet"},{"key":"2019041121361173100_B94","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","article-title":"LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy","volume":"24","author":"Shackleton","year":"2000","journal-title":"Nat Genet"},{"key":"2019041121361173100_B95","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","article-title":"Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13","volume":"28","author":"Magr\u00e9","year":"2001","journal-title":"Nat Genet"},{"key":"2019041121361173100_B96","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","article-title":"AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34","volume":"31","author":"Agarwal","year":"2002","journal-title":"Nat Genet"},{"key":"2019041121361173100_B97","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1194\/jlr.R700004-JLR200","article-title":"Thematic review series: adipocyte biology. Lipodystrophies: windows on adipose biology and metabolism","volume":"48","author":"Hegele","year":"2007","journal-title":"J Lipid Res"},{"key":"2019041121361173100_B98","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.2007.02906.x","article-title":"Inherited lipodystrophies and the metabolic syndrome","volume":"67","author":"Monajemi","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121361173100_B99","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbalip.2008.12.014","article-title":"Lipodystrophies: disorders of adipose tissue biology","volume":"1791","author":"Garg","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"2019041121361173100_B100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tem.2010.06.006","article-title":"Central players in inherited lipodystrophies","volume":"21","author":"Jeninga","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"2019041121361173100_B101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000316893","article-title":"Human lipodystrophies: genetic and acquired diseases of adipose tissue","volume":"19","author":"Capeau","year":"2010","journal-title":"Endocr Dev"},{"key":"2019041121361173100_B102","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","article-title":"Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy","volume":"93","author":"Kim","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B103","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1172\/JCI38660","article-title":"Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy","volume":"119","author":"Hayashi","year":"2009","journal-title":"J Clin Invest"},{"key":"2019041121361173100_B104","doi-asserted-by":"crossref","first-page":"e1000874","DOI":"10.1371\/journal.pgen.1000874","article-title":"Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations","volume":"6","author":"Rajab","year":"2010","journal-title":"PLoS Genet"},{"key":"2019041121361173100_B105","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/ajmg.a.33578","article-title":"Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations","volume":"152A","author":"Shastry","year":"2010","journal-title":"Am J Med Genet A"},{"key":"2019041121361173100_B106","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ymgme.2010.06.016","article-title":"A Japanese child with asymptomatic elevation of serum creatine kinase shows PTRF-CAVIN mutation matching with congenital generalized lipodystrophy type 4","volume":"101","author":"Dwianingsih","year":"2010","journal-title":"Mol Genet Metab"},{"key":"2019041121361173100_B107","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/emmm.200900037","article-title":"Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC","volume":"1","author":"Rubio-Cabezas","year":"2009","journal-title":"EMBO Mol Med"},{"key":"2019041121361173100_B108","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1152\/physrev.00046.2003","article-title":"Role of caveolae and caveolins in health and disease","volume":"84","author":"Cohen","year":"2004","journal-title":"Physiol Rev"},{"key":"2019041121361173100_B109","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1194\/jlr.M001016","article-title":"Lipid droplet analysis in caveolin-deficient adipocytes: Alterations in surface phospholipid composition and maturation defects","volume":"51","author":"Blouin","year":"2010","journal-title":"J Lipid Res"},{"key":"2019041121361173100_B110","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cmet.2008.07.008","article-title":"Deletion of Cavin\/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance","volume":"8","author":"Liu","year":"2008","journal-title":"Cell Metab"},{"key":"2019041121361173100_B111","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1399-0004.2009.01365_3.x","article-title":"Lipodystrophy and muscular dystrophy caused by PTRF mutations","volume":"77","author":"de Haan","year":"2010","journal-title":"Clin Genet"},{"key":"2019041121361173100_B112","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng0498-365","article-title":"Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy","volume":"18","author":"Minetti","year":"1998","journal-title":"Nat Genet"},{"key":"2019041121361173100_B113","doi-asserted-by":"crossref","first-page":"14355","DOI":"10.1074\/jbc.M708323200","article-title":"Fat-specific protein 27 regulates storage of triacylglycerol","volume":"283","author":"Keller","year":"2008","journal-title":"J Biol Chem"},{"key":"2019041121361173100_B114","doi-asserted-by":"crossref","first-page":"e2890","DOI":"10.1371\/journal.pone.0002890","article-title":"Up-regulation of mitochondrial activity and acquirement of brown adipose tissue-like property in the white adipose tissue of fsp27 deficient mice","volume":"3","author":"Toh","year":"2008","journal-title":"PLoS One"},{"key":"2019041121361173100_B115","first-page":"2808","article-title":"FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets","volume":"118","author":"Nishino","year":"2008","journal-title":"J Clin Invest"},{"key":"2019041121361173100_B116","first-page":"2693","article-title":"Lipid droplets: FSP27 knockout enhances their sizzle","volume":"118","author":"Puri","year":"2008","journal-title":"J Clin Invest"},{"key":"2019041121361173100_B117","doi-asserted-by":"crossref","first-page":"20890","DOI":"10.1073\/pnas.0704154104","article-title":"The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology","volume":"104","author":"Szymanski","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361173100_B118","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1083\/jcb.200711136","article-title":"Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast","volume":"180","author":"Fei","year":"2008","journal-title":"J Cell Biol"},{"key":"2019041121361173100_B119","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.biochi.2009.01.011","article-title":"Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy","volume":"91","author":"Boutet","year":"2009","journal-title":"Biochimie"},{"key":"2019041121361173100_B120","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2337\/db08-0184","article-title":"The human lipodystrophy gene BSCL2\/seipin may be essential for normal adipocyte differentiation","volume":"57","author":"Payne","year":"2008","journal-title":"Diabetes"},{"key":"2019041121361173100_B121","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ng926","article-title":"Digenic inheritance of severe insulin resistance in a human pedigree","volume":"31","author":"Savage","year":"2002","journal-title":"Nat Genet"},{"key":"2019041121361173100_B122","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.2337\/diabetes.49.12.1967","article-title":"Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1","volume":"49","author":"Newgard","year":"2000","journal-title":"Diabetes"},{"key":"2019041121361173100_B123","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/abbi.2001.2283","article-title":"Gene structure and expression of the targeting subunit, RGL, of the muscle-specific glycogen-associated type 1 protein phosphatase, PP1G","volume":"388","author":"Lann\u00e9r","year":"2001","journal-title":"Arch Biochem Biophys"},{"key":"2019041121361173100_B124","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1128\/MCB.21.8.2683-2694.2001","article-title":"Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G\/RGL","volume":"21","author":"Suzuki","year":"2001","journal-title":"Mol Cell Biol"},{"key":"2019041121361173100_B125","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1371\/journal.pmed.0050027","article-title":"A prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and mice","volume":"5","author":"Savage","year":"2008","journal-title":"PLoS Med"},{"key":"2019041121361173100_B126","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/43185","article-title":"Congenital leptin deficiency is associated with severe early-onset obesity in humans","volume":"387","author":"Montague","year":"1997","journal-title":"Nature"},{"key":"2019041121361173100_B127","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1210\/jc.2005-2633","article-title":"Syndromic obesity and diabetes: changes in body composition with age and mutation analysis of ALMS1 in 12 United Kingdom kindreds with Alstrom syndrome","volume":"91","author":"Minton","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B128","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/db10-1334","article-title":"Genetic defects in human pericentrin are associated with severe insulin resistance and diabetes mellitus","volume":"60","author":"Huang-Doran","year":"2011","journal-title":"Diabetes"},{"key":"2019041121361173100_B129","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM198910123211503","article-title":"The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome","volume":"321","author":"Green","year":"1989","journal-title":"N Engl J Med"},{"key":"2019041121361173100_B130","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1172\/JCI37041","article-title":"Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy","volume":"119","author":"Zaghloul","year":"2009","journal-title":"J Clin Invest"},{"key":"2019041121361173100_B131","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/diacare.22.12.2094","article-title":"All patients with Werner's syndrome are insulin resistant, but only those who also have impaired insulin secretion develop overt diabetes","volume":"22","author":"Yamada","year":"1999","journal-title":"Diabetes Care"},{"key":"2019041121361173100_B132","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4684-7853-2_6","article-title":"Clinical, endocrine and metabolic aspects of the Werner syndrome compared with those of normal aging","volume":"190","author":"Imura","year":"1985","journal-title":"Adv Exp Med Biol"},{"key":"2019041121361173100_B133","first-page":"111","article-title":"Evaluation of short stature, carbohydrate metabolism and other endocrinopathies in Bloom's syndrome","volume":"66","author":"Diaz","year":"2006","journal-title":"Horm Res"},{"key":"2019041121361173100_B134","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymgme.2005.10.018","article-title":"Laminopathies: multisystem dystrophy syndromes","volume":"87","author":"Jacob","year":"2006","journal-title":"Mol Genet Metab"},{"key":"2019041121361173100_B135","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJM197006182822503","article-title":"An unusual form of diabetes mellitus in ataxia telangiectasia","volume":"282","author":"Schalch","year":"1970","journal-title":"N Engl J Med"},{"key":"2019041121361173100_B136","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00007611-199606000-00013","article-title":"Insulin-resistant diabetes mellitus in a black woman with ataxia-telangiectasia","volume":"89","author":"Blevins","year":"1996","journal-title":"South Med J"},{"key":"2019041121361173100_B137","doi-asserted-by":"crossref","first-page":"b847","DOI":"10.1136\/bmj.b847","article-title":"Management of hirsutism","volume":"338","author":"Koulouri","year":"2009","journal-title":"BMJ"},{"key":"2019041121361173100_B138","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D37MF6G290","article-title":"Acanthosis nigricans: a practical approach to evaluation and management","volume":"14","author":"Higgins","year":"2008","journal-title":"Dermatol Online J"},{"key":"2019041121361173100_B139","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2337\/diacare.28.5.1240","article-title":"The use of U-500 in patients with extreme insulin resistance","volume":"28","author":"Cochran","year":"2005","journal-title":"Diabetes Care"},{"key":"2019041121361173100_B140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4158\/EP.12.3.251","article-title":"Use of U-500 regular insulin by continuous subcutaneous insulin infusion in patients with type 2 diabetes and severe insulin resistance","volume":"12","author":"Lane","year":"2006","journal-title":"Endocr Pract"},{"key":"2019041121361173100_B141","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s001250050695","article-title":"A homozygous kinase-defective mutation in the insulin receptor gene in a patient with leprechaunism","volume":"40","author":"Takahashi","year":"1997","journal-title":"Diabetologia"},{"key":"2019041121361173100_B142","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1210\/jcem.83.2.4602","article-title":"Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism","volume":"83","author":"Nakae","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B143","first-page":"799","article-title":"Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and insulin-like growth factor-I","volume":"79","author":"Longo","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B144","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/eje.0.1360475","article-title":"Short- and long-term metabolic effects of recombinant human IGF-I treatment in patients with severe insulin resistance and diabetes mellitus","volume":"136","author":"Vestergaard","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"2019041121361173100_B145","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/diab.42.5.696","article-title":"Trial of insulin-like growth factor I therapy for patients with extreme insulin resistance syndromes","volume":"42","author":"Kuzuya","year":"1993","journal-title":"Diabetes"},{"key":"2019041121361173100_B146","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/eje.0.1310251","article-title":"Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A","volume":"131","author":"Zenobi","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"2019041121361173100_B147","first-page":"1325","article-title":"In vivo metabolic effects of insulin-like growth factor-I not mediated through the insulin receptor","volume":"80","author":"Dozio","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B148","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1677\/joe.0.1410177","article-title":"Response of insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) and IGFBP-3 to IGF-I treatment in severe insulin resistance","volume":"141","author":"Quin","year":"1994","journal-title":"J Endocrinol"},{"key":"2019041121361173100_B149","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/en.2002-220815","article-title":"Deletion of V335 from the L2 domain of the insulin receptor results in a conformationally abnormal receptor that is unable to bind insulin and causes Donohue's syndrome in a human subject","volume":"144","author":"George","year":"2003","journal-title":"Endocrinology"},{"key":"2019041121361173100_B150","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1530\/EJE-07-0271","article-title":"IGF-I treatment of insulin resistance","volume":"157","author":"McDonald","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"2019041121361173100_B151","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1210\/jc.2009-2088","article-title":"Treatment with recombinant human insulin-like growth factor (rhIGF)-I\/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance","volume":"95","author":"Regan","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B152","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","article-title":"Serum adiponectin and leptin levels in patients with lipodystrophies","volume":"87","author":"Haque","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B153","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"key":"2019041121361173100_B154","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy","volume":"109","author":"Petersen","year":"2002","journal-title":"J Clin Invest"},{"key":"2019041121361173100_B155","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.20672","article-title":"Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy","volume":"41","author":"Javor","year":"2005","journal-title":"Hepatology"},{"key":"2019041121361173100_B156","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1542\/peds.2006-3165","article-title":"Metabolic correction induced by leptin replacement treatment in young children with Berardinelli-Seip congenital lipoatrophy","volume":"120","author":"Beltrand","year":"2007","journal-title":"Pediatrics"},{"key":"2019041121361173100_B157","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00125-009-1502-9","article-title":"Efficacy of leptin therapy in the different forms of human lipodystrophy","volume":"53","author":"Chong","year":"2010","journal-title":"Diabetologia"},{"key":"2019041121361173100_B158","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1530\/EJE-09-1027","article-title":"Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin","volume":"162","author":"Beltrand","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2019041121361173100_B159","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00125-009-1545-y","article-title":"Leptin therapy in lipodystrophy","volume":"53","author":"Savage","year":"2010","journal-title":"Diabetologia"},{"key":"2019041121361173100_B160","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1210\/jc.2009-0340","article-title":"Whither recombinant human leptin treatment for HIV-associated lipoatrophy and the metabolic syndrome?","volume":"94","author":"Mantzoros","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B161","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1210\/jc.2003-031952","article-title":"Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome","volume":"89","author":"Cochran","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B162","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1210\/jc.2009-0543","article-title":"Thyroid hormone induced brown adipose tissue and amelioration of diabetes in a patient with extreme insulin resistance","volume":"95","author":"Skarulis","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B163","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1007\/s00125-010-1879-5","article-title":"Multidrug therapy in a patient with Rabson-Mendenhall syndrome","volume":"53","author":"Moreira","year":"2010","journal-title":"Diabetologia"},{"key":"2019041121361173100_B164","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2337\/dc06-0130","article-title":"Effectiveness of gastric bypass surgery in a patient with familial partial lipodystrophy","volume":"29","author":"Utzschneider","year":"2006","journal-title":"Diabetes Care"},{"key":"2019041121361173100_B165","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI11245","article-title":"Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones","volume":"106","author":"Chao","year":"2000","journal-title":"J Clin Invest"},{"key":"2019041121361173100_B166","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.diabet.2007.04.005","article-title":"Efficacy of pioglitazone in familial partial lipodystrophy of the Dunnigan type: a case report","volume":"33","author":"Moreau","year":"2007","journal-title":"Diabetes Metab"},{"key":"2019041121361173100_B167","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1463-1326.2008.00978.x","article-title":"Prolonged thiazolidinedione therapy does not reverse fat loss in patients with familial partial lipodystrophy, Dunnigan variety","volume":"10","author":"Simha","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"2019041121361173100_B168","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.diabet.2009.01.001","article-title":"Long-term improvement of metabolic control with pioglitazone in a woman with diabetes mellitus related to Dunnigan syndrome: a case report","volume":"35","author":"Collet-Gaudillat","year":"2009","journal-title":"Diabetes Metab"},{"key":"2019041121361173100_B169","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00125-010-1724-x","article-title":"Analysis of TBC1D4 in patients with severe insulin resistance","volume":"53","author":"Dash","year":"2010","journal-title":"Diabetologia"},{"key":"2019041121361173100_B170","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa022050","article-title":"Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene","volume":"348","author":"Farooqi","year":"2003","journal-title":"N Engl J Med"},{"key":"2019041121361173100_B171","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/509","article-title":"Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans","volume":"19","author":"Krude","year":"1998","journal-title":"Nat Genet"},{"key":"2019041121361173100_B172","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/32911","article-title":"A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction","volume":"392","author":"Cl\u00e9ment","year":"1998","journal-title":"Nature"},{"key":"2019041121361173100_B173","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature08689","article-title":"Large, rare chromosomal deletions associated with severe early-onset obesity","volume":"463","author":"Bochukova","year":"2010","journal-title":"Nature"},{"key":"2019041121361173100_B174","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jmg.39.10.722","article-title":"Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy","volume":"39","author":"Van Maldergem","year":"2002","journal-title":"J Med Genet"},{"key":"2019041121361173100_B175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/qjmed\/90.1.27","article-title":"Dunnigan-Kobberling syndrome: an autosomal dominant form of partial lipodystrophy","volume":"90","author":"Jackson","year":"1997","journal-title":"QJM"},{"key":"2019041121361173100_B176","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1172\/JCI28003","article-title":"PPAR \u03b3 and human metabolic disease","volume":"116","author":"Semple","year":"2006","journal-title":"J Clin Invest"},{"key":"2019041121361173100_B177","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2337\/diabetes.52.4.910","article-title":"Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-\u03b3","volume":"52","author":"Savage","year":"2003","journal-title":"Diabetes"},{"key":"2019041121361173100_B178","first-page":"408","article-title":"A novel heterozygous mutation in peroxisome proliferator-activated receptor-\u03b3 gene in a patient with familial partial lipodystrophy","volume":"87","author":"Agarwal","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361173100_B179","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.2337\/diabetes.51.12.3586","article-title":"PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy","volume":"51","author":"Hegele","year":"2002","journal-title":"Diabetes"},{"key":"2019041121361173100_B180","first-page":"23S","article-title":"Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus","volume":"118","author":"Grinspoon","year":"2005","journal-title":"Am J Med"},{"key":"2019041121361173100_B181","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ana.410150208","article-title":"Whole body insulin resistance in myotonic dystrophy","volume":"15","author":"Moxley","year":"1984","journal-title":"Ann Neurol"},{"key":"2019041121361173100_B182","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ng704","article-title":"Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy","volume":"29","author":"Savkur","year":"2001","journal-title":"Nat Genet"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/32\/4\/498\/8858484\/edrv0498.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T16:47:37Z","timestamp":1712681257000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/32\/4\/498\/2354745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,2]]},"references-count":182,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,5,2]]},"published-print":{"date-parts":[[2011,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2010-0020","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,2]]}}}